TFIIH p89 Antibodies

Santa Cruz Biotechnology delivers a wide array of TFIIH p89 monoclonal antibodies for research focused on understanding this essential protein. TFIIH p89 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TFIIH p89 is a critical component of the transcription factor IIH complex, which is involved in DNA repair and transcription initiation. Its function is vital for maintaining genomic stability and regulating gene expression, making it an important target for studies related to cancer and other diseases. Understanding TFIIH p89 can provide insights into the mechanisms of cellular response to DNA damage and the regulation of transcriptional processes. TFIIH p89 research has revealed significant implications in various cellular pathways and disease mechanisms. Investigating TFIIH p89 continues to uncover new aspects of transcription regulation and DNA repair mechanisms. Recent studies have highlighted TFIIH p89's role in maintaining cellular homeostasis and its potential as a therapeutic target. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TFIIH p89's role in human health and disease.